All In Biotech

Drug Trial Radar · NCT01516138

Benefits of GIK in Cardiac Surgery Patients

Myocardial Protection of Glucose - Insulin - Potassium in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Last checked: Nov 20, 2026Latest source record: Oct 31, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 930 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

930

Actual

Start

Feb 2012

Primary completion

Mar 2013

Study completion Feb 2022

Sponsor

Lead sponsor
Xijing HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 24, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effects of modified glucose - insulin - potassium (GIK) therapy in cardiac surgery patients undergoing cardiopulmonary bypass (CPB).

Conditions

  • Cardiac Surgery
  • Cardiopulmonary Bypass

Interventions

  • GIKDrug

    Intravenous solution was started at about 10 minutes before general anesthesia, running at a rate of 1 mL/kg/h for 12.5 hours.

  • ControlDrug

    Intravenous solution was started at about 10 minutes before general anesthesia, running at a rate of 1 mL/kg/h for 12.5 hours.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants of the major adverse cardiac eventsTime frame: Stay in hospital

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Deparment of Cardiovascular surgery,Xijing Hospital, Fourth Military Medical University

    Xi'an, Shaanxi, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.